- Report
- October 2024
- 24 Pages
Peru
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 22 Pages
Finland
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 24 Pages
Portugal
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 28 Pages
South Korea
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 23 Pages
Netherlands
From €995EUR$1,079USD£857GBP
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 24 Pages
Spain
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 21 Pages
Croatia
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 26 Pages
Malaysia
From €995EUR$1,079USD£857GBP
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 22 Pages
Bulgaria
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 22 Pages
Denmark
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 23 Pages
Greece
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 24 Pages
Hungary
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 25 Pages
Czech Republic
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 23 Pages
Bolivia
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 25 Pages
Colombia
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 23 Pages
Georgia
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 24 Pages
Philippines
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 28 Pages
China, Hong Kong
From €995EUR$1,079USD£857GBP
The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more